AAAAAA
Results: 101-125/314
Authors:
GAYET JC
FORTIER G
Citation: Jc. Gayet et G. Fortier, DRUG-RELEASE FROM NEW BIOARTIFICIAL HYDROGEL, Artificial cells, blood substitutes, and immobilization biotechnology, 23(5), 1995, pp. 605-611
Authors:
KOEBE HG
MUELLERHOECKER J
KOEBE S
SCHILDBERG FW
Citation: Hg. Koebe et al., VIABLE PORCINE HEPATOCYTES FROM SLAUGHTERHOUSE ORGANS, Artificial cells, blood substitutes, and immobilization biotechnology, 23(5), 1995, pp. 613-626
Authors:
BLEEKER WK
ZAPPEIJ LM
DENBOER PJ
AGTERBERG JA
RIGTER GMM
BAKKER JC
Citation: Wk. Bleeker et al., EVALUATION OF THE IMMUNOGENICITY OF POLYMERIZED HEMOGLOBIN-SOLUTIONS IN A RABBIT MODEL, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 461-468
Authors:
SIMONI J
SIMONI G
GARCIA EL
PRIEN SD
TRAN RM
FEOLA M
SHIRES GT
Citation: J. Simoni et al., PROTECTIVE EFFECT OF SELENIUM ON HEMOGLOBIN MEDIATED LIPID-PEROXIDATION IN-VIVO, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 469-486
Authors:
JING M
LEDVINA MA
BINA S
HART JL
MULDOON SM
Citation: M. Jing et al., EFFECTS OF HALOGENATED AND NONHALOGENATED ANESTHETICS ON DIASPIRIN CROSS-LINKED HEMOGLOBIN(TM)-INDUCED CONTRACTIONS OF PORCINE PULMONARY VEINS, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 487-494
Authors:
FAIVRE B
LABAEYE V
MENU P
LABRUDE P
VIGNERON C
Citation: B. Faivre et al., ASSESSMENT OF DEXTRAN 10-BENZENE-TETRACARBOXYLATE-HEMOGLOBIN, AN OXYGEN CARRIER, USING GUINEA-PIG ISOLATED BOWEL MODEL, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 495-504
Authors:
NISHIYA T
LAM RTT
ENG F
ZEREY M
LAU S
Citation: T. Nishiya et al., MECHANISTIC STUDY ON TOXICITY OF POSITIVELY CHARGED LIPOSOMES CONTAINING STEARYLAMINE TO BLOOD, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 505-512
Authors:
ZHAO L
SMITH JR
EYER CL
Citation: L. Zhao et al., EFFECTS OF A 100-PERCENT PERFLUOROOCTYLBROMIDE EMULSION ON ISCHEMIA-REPERFUSION INJURY FOLLOWING CARDIOPLEGIA, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 513-531
Authors:
ZIHNIOGLU F
TELEFONCU A
Citation: F. Zihnioglu et A. Telefoncu, SUBSTRATE-SPECIFICITY AND THE USE OF CHITOSAN-ENTRAPPED RABBIT HEPATIC-MICROSOMAL UDP-GLUCURONYL TRANSFERASE FOR DETOXIFICATION, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 533-543
Authors:
ZIHNIOGLU F
TELEFONCU A
Citation: F. Zihnioglu et A. Telefoncu, PREPARATION AND CHARACTERIZATION OF CHITOSAN-ENTRAPPED MICROSOMAL UDP-GLUCURONYL TRANSFERASE, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 545-552
Authors:
CHANG TMS
Citation: Tms. Chang, CROSS-LINKED HEMOGLOBINS BEING WELL INTO CLINICAL-TRIALS, INCREASING RESEARCH EFFORTS ARE NOW ON A 2ND GENERATION RED-BLOOD-CELL SUBSTITUTEBASED ON ENCAPSULATED HEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 257-262
Authors:
ULATOWSKI JA
KOEHLER RC
NISHIKAWA T
TRAYSTMAN RJ
RAZYNSKA A
KWANSA H
URBAITIS B
BUCCI E
Citation: Ja. Ulatowski et al., ROLE OF NITRIC-OXIDE SCAVENGING IN PERIPHERAL VASOCONSTRICTOR RESPONSE TO BETA-BETA CROSS-LINKED HEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 263-269
Authors:
GREENBURG AG
KIM HW
Citation: Ag. Greenburg et Hw. Kim, NITROSYL HEMOGLOBIN-FORMATION IN-VIVO AFTER INTRAVENOUS ADMINISTRATION OF A HEMOGLOBIN-BASED OXYGEN CARRIER IN ENDOTOXEMIC RATS, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 271-276
Authors:
HESS JR
Citation: Jr. Hess, REVIEW OF MODIFIED HEMOGLOBIN RESEARCH AT LETTERMAN - ATTEMPTS TO DELINEATE THE TOXICITY OF CELL-FREE TETRAMERIC HEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 277-289
Authors:
MOTTERLINI R
FORESTI R
VANDERGRIFF K
WINSLOW RM
Citation: R. Motterlini et al., THE AUTOXIDATION OF ALPHA-ALPHA CROSS-LINKED HEMOGLOBIN - A POSSIBLE ROLE IN THE OXIDATIVE STRESS TO ENDOTHELIUM, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 291-301
Authors:
KIM HW
GREENBURG AG
Citation: Hw. Kim et Ag. Greenburg, HEMOGLOBIN MEDIATED VASOACTIVITY IN ISOLATED VASCULAR RINGS, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 303-309
Authors:
MANJULA BN
SMITH PK
MALAVALLI A
ACHARYA AS
Citation: Bn. Manjula et al., INTRAMOLECULAR CROSS-LINKING OF OXY HEMOGLOBIN BY BIS SULFOSUCCINIMIDYL SUBERATE AND SEBACATE - GENERATION OF CROSS-LINKED HEMOGLOBIN WITH REDUCED OXYGEN-AFFINITY, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 311-318
Authors:
MENU P
DONNER M
FAIVRE B
LABRUDE P
VIGNERON C
Citation: P. Menu et al., IN-VITRO EFFECT OF DEXTRAN BENZENE-TETRA-CARBOXYLATE HEMOGLOBIN ON HUMAN BLOOD RHEOLOGICAL PROPERTIES, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 319-330
Authors:
CLIFF RO
KWASIBORSKI V
RUDOLPH AS
Citation: Ro. Cliff et al., A COMPARATIVE-STUDY OF THE ACCURATE MEASUREMENT OF ENDOTOXIN IN LIPOSOME-ENCAPSULATED HEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 331-336
Authors:
USUBA A
MOTOKI R
OGATA Y
SUZUKI K
KAMITANI T
Citation: A. Usuba et al., EFFECT AND SAFETY OF LIPOSOME-ENCAPSULATED HEMOGLOBIN NEO RED-CELLS (NRCS) AS A PERFUSATE FOR TOTAL CARDIOPULMONARY BYPASS, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 337-346
Authors:
TAKAHASHI A
Citation: A. Takahashi, CHARACTERIZATION OF NEO RED-CELLS (NRCS), THEIR FUNCTION AND SAFETY IN-VIVO TESTS, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 347-354
Authors:
SZEBENI J
WASSEF NM
RUDOLPH AS
ALVING CR
Citation: J. Szebeni et al., COMPLEMENT ACTIVATION BY LIPOSOME-ENCAPSULATED HEMOGLOBIN IN-VITRO - THE ROLE OF ENDOTOXIN CONTAMINATION, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 355-363
Authors:
SPENCE RK
Citation: Rk. Spence, PERFLUOROCARBONS IN THE 21ST CENTURY - CLINICAL-APPLICATIONS AS TRANSFUSION ALTERNATIVES, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 367-380
Authors:
KEIPERT PE
Citation: Pe. Keipert, USE OF OXYGENT(TM), A PERFLUOROCHEMICAL-BASED OXYGEN CARRIER, AS AN ALTERNATIVE TO INTRAOPERATIVE BLOOD-TRANSFUSION, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 381-394
Authors:
TEICHER BA
Citation: Ba. Teicher, AN OVERVIEW ON OXYGEN CARRIERS IN CANCER-THERAPY, Artificial cells, blood substitutes, and immobilization biotechnology, 23(3), 1995, pp. 395-405